4Auslender M. Pathophysiology of pediatric heart failure[J]. Prog Pediatr Cardiol, 2000.11(3):175-184.
5Sirvio ML, Helin K, Stewen P, et al. Endothelin-1 in heart and pulmonary tissue in experimental heart failure[J]. Blood Pressure, 1997,6(4):250-255.
6Bemadin G, Strosberg AD, Bernard A. Beta-adrenergic receptor-dependent and independent stimulation of adenylate cyclase is impaired during severe sepsis in human [J]. Intensive Care Med, 1998,24(12):1315-1322.
7Braunwald E, Bristow MR. Congestive heart failure: fifty years of progress[ J]. Circulation, 2000,102(20):IV 14-23.
8Brunner HP,Rocca MD,Vaddadi G, et ol. Recent insight into therapy of congestive heart failure: focus on ACE inhibition and angiotensin-Ⅱ antagonoism[J] .J Am Coil Cardiol, 1999,33(5):1163-1173.
9Chung O, Kuhl H, StoU M, et al. Physiological and pharmaeo-logical implications of AT1 versus AT2 receptors[J]. Kidney Int, 1998, 67[Suppl]:S95-S99.
10Yoshihara F, Nishikimi T, Horio T, et al. Chronic infusion of adrenomedullin reduces pulmonary hypertension and lessens fight ventricular hypertrophy in rats administered monolocular[J]. Eur J Pharmacol, 1998,355(1):33-39.
